Cencora, Inc. announced on November 5, 2024, that it has entered into a definitive agreement to acquire Retina Consultants of America (RCA) for approximately $4.6 billion in cash. The acquisition also includes potential contingent consideration of up to $500 million in fiscal years 2027 and 2028, subject to predefined business objectives.
This strategic move is expected to broaden Cencora’s relationships with community providers in the high-growth retina specialty segment and build on its leadership in specialty healthcare. Cencora will hold approximately 85% ownership in RCA upon closing, with RCA's affiliated practices, physicians, and management retaining a minority interest.
The transaction is anticipated to be approximately $0.35 accretive to Cencora’s adjusted diluted EPS for its first twelve months, net of estimated financing costs. Cencora plans to fund the acquisition through a combination of existing cash on hand and new debt financing, with a commitment to prioritizing deleveraging post-close.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.